Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection

Holton, 2012 Vakil, 2007, Eradication therapy for Helicobacter pylori, Gastroenterology, 133, 985, 10.1053/j.gastro.2007.07.008 Gatta, 2018, Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains, Aliment. Pharmacol. Ther., 47, 1261, 10.1111/apt.14597 Malfertheiner, 2017, Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report, Gut, 66, 6, 10.1136/gutjnl-2016-312288 Zagari, 2015, Guidelines for the management of helicobacter pylori infection in Italy: the III working group consensus report 2015, Dig Liver Dis, 47, 903, 10.1016/j.dld.2015.06.010 Available online:http://www.eucast.org/clinical_breakpoints (accessed on 07 january 2020). Newcombe, 2000 Chey, 2017, ACG clinical guideline: treatment of Helicobacter pylori infection, Am. J. Gastroenterol., 112, 212, 10.1038/ajg.2016.563 McColl, 2010, Clinical practice. Helicobacter pylori infection, N. Engl. J. Med, 362, 1597, 10.1056/NEJMcp1001110 Megraud, 2003, Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption, Gut, 62, 34, 10.1136/gutjnl-2012-302254 De Francesco, 2019, Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication, J Antimicrob Chemother, 74, 772, 10.1093/jac/dky469 Graham, 2016, Helicobacter pylori therapy: a paradigm shift, Expert Rev Anti Infect. Ther., 14, 577, 10.1080/14787210.2016.1178065 Dang, 2017, Helicobacter pylori infection and antibiotic resistance: a WHO high priority?, Nat Rev Gastroenterol Hepatol, 14, 383, 10.1038/nrgastro.2017.57 Bell, 2014, A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance, BMC Infect. Dis., 14, 13, 10.1186/1471-2334-14-13 Savoldi, 2018, Prevalence of antibiotic resistance in helicobacter pylori: a Systematic Review and Meta-analysis in World Health Organization Regions, Gastroenterology, 155, 1372, 10.1053/j.gastro.2018.07.007 Song, 2014, Tiing Leong Ang Second and third line treatment options for Helicobacter pylori eradication, World J Gastroenterol, 14, 1517, 10.3748/wjg.v20.i6.1517 González Carro, 2007, Efficacy of rifabutin-based triple therapy in Helicobacter pylori infected patients after two standard treatments, J Gastroenterol Hepatol, 22, 60, 10.1111/j.1440-1746.2006.04375.x Gisbert, 2012, Review article: rifabutin in the treatment of refractory Helicobacter pylori infection, Aliment Pharmacol Ther, 35, 209, 10.1111/j.1365-2036.2011.04937.x Fiorini, 2013, culture-based rescue therapy for patients who did not respond to previous treatments for Helicobacter pylori infection, Clinical Gastroenterology and Hepatology, 11, 507, 10.1016/j.cgh.2012.12.007 Saracino, 2020, Antibiotic resistance and therapy outcome in h. pylori eradication failure patients, Antibiotics Zullo, 2017, Bismuth-based Quadruple Therapy Following H. Pylori Eradication Failures: a Multicenter Study in Clinical Practice, Eur J Gastroenterol Hepatol, 30, 621 Fiorini, 2017, Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori—Resistant strains, Helicobacter, 22, e12448, 10.1111/hel.12448 Zullo, 2020, The current role of dual therapy for treatment of Helicobacter pylori: back to the future?, Eur. J. Gastroenterol. Hepatol, 10.1097/MEG.0000000000001654